Rafferty Asset Management, LLC Capricor Therapeutics, Inc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 82,988 shares of CAPR stock, worth $765,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,988
Previous 126,311
34.3%
Holding current value
$765,149
Previous $1.75 Million
55.0%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
139Shares Held
17.1MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$20.9 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$20.7 Million0.12% of portfolio
-
State Street Corp Boston, MA1.84MShares$17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$8.31 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $224M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...